Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frank Griesinger

Showing results (71-80 of 159) with videos related to

Pageof 16
Sort By:
The Lancet. Oncology|July 24, 2010
Safety and efficacy of first-line bevacizumab-based therapy in advanced non-squamous non-small-cell lung cancer (SAiL, MO19390): a phase 4 studyLucio Crinò, Eric Dansin, Pilar Garrido, et al.
Clinical Lung Cancer|June 28, 2011
Randomized phase IIIb trial evaluating the continuation of bevacizumab beyond disease progression in patients with advanced non-squamous non-small-cell lung cancer after first-line treatment with bevacizumab plus platinum-based chemotherapy: treatment rationale and protocol dynamics of the AvaALL (MO22097) trialCesare Gridelli, Jaafar Bennouna, Javier de Castro, et al.
Drugs - Real World Outcomes|September 17, 2021
European and US Real-World Treatment Patterns in Patients with Epidermal Growth Factor Receptor Mutation-Positive Non-Small Cell Lung Cancer: A Retrospective Medical Record ReviewRiyaz Shah, Nicolas Girard, Saurabh P Nagar, et al.
Oncology Research and Treatment|April 18, 2019
Clinical Experience of Immunotherapy Treatment: Efficacy and Toxicity Analysis of the Compassionate Use Program of Nivolumab in Patients with Advanced Squamous Cell Non-Small Cell Lung CancerFrederik Krefting, Nadezda Basara, Wolfgang Schütte, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|June 7, 2003
Molecular whole-body cancer staging using positron emission tomography: consequences for therapeutic management and metabolic radiation treatment planningMichael Schmücking, Richard P Baum, Frank Griesinger, et al.
Annals of Hematology|September 14, 2014
Prognostic impact of intraocular involvement in primary CNS lymphoma: experience from the G-PCNSL-SG1 trialStephan Kreher, Felicitas Strehlow, Peter Martus, et al.
Journal of Cancer Research and Clinical Oncology|April 24, 2017
Early whole brain radiotherapy in primary CNS lymphoma: negative impact on quality of life in the randomized G-PCNSL-SG1 trialUlrich Herrlinger, Niklas Schäfer, Rolf Fimmers, et al.
Journal of Geriatric Oncology|November 2, 2022
Older patients with EGFR mutation-positive non-small cell lung cancer treated with afatinib in clinical practice: A subset analysis of the non-interventional GIDEON studyWolfgang M Brueckl, Martin Reck, Harald Schäfer, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 12, 2016
International Experts Panel Meeting of the Italian Association of Thoracic Oncology on Antiangiogenetic Drugs for Non-Small Cell Lung Cancer: Realities and HopesFilippo de Marinis, Emilio Bria, Fortunato Ciardiello, et al.
Oncology Research and Treatment|April 1, 2025
Thoracic Oncology Highlights from the European Society for Medical Oncology Annual Meeting 2024: Non-Targeted therapy in Non-Small Cell Lung Cancer, Small Cell Lung Cancer and Thymic Epithelial TumorsMarie-Elisabeth Leßmann, Christine Sibbert, Lea Reitnauer, et al.
Pageof 16

Showing results (71-80 of 159) with videos related to

Sort By:
Pageof 16
The Lancet. Oncology|July 24, 2010
Safety and efficacy of first-line bevacizumab-based therapy in advanced non-squamous non-small-cell lung cancer (SAiL, MO19390): a phase 4 studyLucio Crinò, Eric Dansin, Pilar Garrido, et al.
Clinical Lung Cancer|June 28, 2011
Randomized phase IIIb trial evaluating the continuation of bevacizumab beyond disease progression in patients with advanced non-squamous non-small-cell lung cancer after first-line treatment with bevacizumab plus platinum-based chemotherapy: treatment rationale and protocol dynamics of the AvaALL (MO22097) trialCesare Gridelli, Jaafar Bennouna, Javier de Castro, et al.
Drugs - Real World Outcomes|September 17, 2021
European and US Real-World Treatment Patterns in Patients with Epidermal Growth Factor Receptor Mutation-Positive Non-Small Cell Lung Cancer: A Retrospective Medical Record ReviewRiyaz Shah, Nicolas Girard, Saurabh P Nagar, et al.
Oncology Research and Treatment|April 18, 2019
Clinical Experience of Immunotherapy Treatment: Efficacy and Toxicity Analysis of the Compassionate Use Program of Nivolumab in Patients with Advanced Squamous Cell Non-Small Cell Lung CancerFrederik Krefting, Nadezda Basara, Wolfgang Schütte, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|June 7, 2003
Molecular whole-body cancer staging using positron emission tomography: consequences for therapeutic management and metabolic radiation treatment planningMichael Schmücking, Richard P Baum, Frank Griesinger, et al.
Annals of Hematology|September 14, 2014
Prognostic impact of intraocular involvement in primary CNS lymphoma: experience from the G-PCNSL-SG1 trialStephan Kreher, Felicitas Strehlow, Peter Martus, et al.
Journal of Cancer Research and Clinical Oncology|April 24, 2017
Early whole brain radiotherapy in primary CNS lymphoma: negative impact on quality of life in the randomized G-PCNSL-SG1 trialUlrich Herrlinger, Niklas Schäfer, Rolf Fimmers, et al.
Journal of Geriatric Oncology|November 2, 2022
Older patients with EGFR mutation-positive non-small cell lung cancer treated with afatinib in clinical practice: A subset analysis of the non-interventional GIDEON studyWolfgang M Brueckl, Martin Reck, Harald Schäfer, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 12, 2016
International Experts Panel Meeting of the Italian Association of Thoracic Oncology on Antiangiogenetic Drugs for Non-Small Cell Lung Cancer: Realities and HopesFilippo de Marinis, Emilio Bria, Fortunato Ciardiello, et al.
Oncology Research and Treatment|April 1, 2025
Thoracic Oncology Highlights from the European Society for Medical Oncology Annual Meeting 2024: Non-Targeted therapy in Non-Small Cell Lung Cancer, Small Cell Lung Cancer and Thymic Epithelial TumorsMarie-Elisabeth Leßmann, Christine Sibbert, Lea Reitnauer, et al.
Pageof 16